Missing Links? Citation Matrix Graphs Glossary  HistCite Guide  About
Wed Oct 27 15:03:40 2004

Papers with "thalidomide" in the title, 1980-2004

Nodes: 1975, Authors: 5409, Journals: 512, Outer References: 13295, Words: 3300
Collection span: 1980 - 2004
View: Overview. Sorted by LCR.
Page 1:  1  2  3  4  5  6  7
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
11562211706 2003 CLINICAL THERAPEUTICS 25(2):342-395
Matthews SJ; McCoy C
Thalidomide: A review of approved and investigational uses
26
21511871581 2003 ANNALS OF PHARMACOTHERAPY 37(9):1307-1320
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Dermatologic and nondermatologic uses of thalidomide
11
31281591943 2004 LANCET 363(9423):1802-1811
Franks ME; Macpherson GR; Figg WD
Thalidomide
00
41021641440 2002 DRUGS & AGING 19(2):85-100
Zhou SF; Kestell P; Tingle MD; Paxton JW
Thalidomide in cancer treatment - A potential role in the elderly?
45
5991911087 2001 BIODRUGS 15(10):681-703
Meierhofer C; Dunzendorfer S; Wiedermann CJ
Theoretical basis for the activity of thalidomide
714
6921481028 2000 NATIONAL MEDICAL JOURNAL OF INDIA 13(3):132-141
Grover JK; Vats V; Gopalakrishna R; Ramam M
Thalidomide: A re-look
23
7921151177 2001 DERMATOLOGIC CLINICS 19(1):87-+
Radomsky CL; Levine N
Thalidomide
48
885116881 2000 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 127(6-7):603-613
Laffitte E; Revuz J
Thalidomide
79
9801181415 2002 CANCER INVESTIGATION 20(5-6):835-848
Baidas S; Tfayli A; Bhargava P
Thalidomide: An old drug with new clinical applications
13
1075113894 2000 BIODRUGS 13(4):255-265
Kontogiannis V; Powell RJ
Use of thalidomide in dermatological indications
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
11751301423 2002 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 20(5):709-718
Ossandon A; Cassara EAM; Priori R; Valesini G
Thalidomide: focus on its employment in rheumatologic diseases
24
1274101546 1996 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 35(6):969-979
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
78117
13731441720 2003 EXPERT OPINION ON INVESTIGATIONAL DRUGS 12(7):1211-1225
Fanelli M; Sarmiento R; Gattuso D; Carillio G; Capaccetti B; Vacca A; Roccaro AM; Gasparini G
Thalidomide: a new anticancer drug?
37
1470821843 2004 ANNALS OF ONCOLOGY 15(8):1151-1160
Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA
Thalidomide in cancer medicine
00
1569136868 1999 TERATOLOGY 60(5):306-321
Miller MT; Stromland K
Teratogen update: Thalidomide: A review, with a focus on ocular findings and new potential uses
719
16691041826 2003 SWISS MEDICAL WEEKLY 133(5-6):77-87
von Moos R; Stolz R; Cerny T; Gillessen S
Thalidomide: from tragedy to promise
11
176687742 1998 SEMINARS IN CUTANEOUS MEDICINE AND SURGERY 17(4):231-242
Stirling DI
Thalidomide and its impact in dermatology
1417
1866771814 2003 POSTGRADUATE MEDICAL JOURNAL 79(929):127-132
Gordon JN; Goggin PM
Thalidomide and its derivatives: emerging from the wilderness
03
1964215541 1996 JOURNAL OF INFLAMMATION 46(4):177-211
Zwingenberger K; Wnendt S
Immunomodulation by thalidomide: Systematic review of the literature and of unpublished observations
3338
20631121298 2002 ANNUAL REVIEW OF MEDICINE 53:629-657
Richardson P; Hideshima T; Anderson K
Thalidomide: Emerging role in cancer medicine
2336
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
216296877 2000 AMERICAN JOURNAL OF MEDICINE 108(6):487-495
Calabrese L; Fleischer AB
Thalidomide: Current and potential clinical applications
60103
2259871188 2001 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 57(5):365-376
Eriksson T; Bjorkman S; Hoglund P
Clinical pharmacology of thalidomide
2232
23581161072 2001 ANNALS OF MEDICINE 33(8):516-525
Ginsburg PM; Dassopoulos T; Ehrenpreis ED
Thalidomide treatment for refractory Crohn's disease: a review. of the history, pharmacological mechanisms and clinical literature
913
24581071433 2002 CROATIAN MEDICAL JOURNAL 43(3):274-285
Mujagic H; Chabner BA; Mujagic Z
Mechanisms of action and potential therapeutic uses of thalidomide
12
2557821432 2002 CRITICAL REVIEWS IN IMMUNOLOGY 22(5-6):425-437
Dredge K; Marriott JB; Dalgleish AG
Immunological effects of thalidomide and its chemical and functional analogs
02
2657701739 2003 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 785(1):165-173
Zhou SF; Lia Y; Kestell P; Paxton JW
Determination of thalidomide in transport buffer for Caco-2 cell monolayers by high-performance liquid chromatography with ultraviolet detection
00
2753611307 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):4-12
Singhal S; Mehta J
Thalidomide in cancer
1721
2853611541 2002 ORAL ONCOLOGY 38(6):527-531
Porter SR; Jorge J
Thalidomide: a role in oral oncology?
01
2951221964 2000 CLINICS IN DERMATOLOGY 18(1):131-145
Sanchez MR
Miscellaneous treatments: Thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine
03
3051961049 2000 SEMINARS IN HEMATOLOGY 37(1):5-14
Stirling DI
Pharmacology of thalidomide
2123
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
3151941747 2003 JOURNAL OF CLINICAL ONCOLOGY 21(23):4444-4454
Dimopoulos MA; Anagnostopoulos A; Weber D
Treatment of plasma cell dyserasias with thalidomide and its derivatives
12
3250731086 2001 BIODRUGS 15(3):163-172
Singhal S; Mehta J
Thalidomide in cancer - Potential uses and limitations
1216
3350931311 2002 BIOMEDICINE & PHARMACOTHERAPY 56(3):115-128
Richardson P; Hideshima T; Anderson K
Thalidomide in multiple myeloma
56
3450831957 2004 MAYO CLINIC PROCEEDINGS 79(7):899-903
Rajkumar SV
Thalidomide: Tragic past and promising future
00
3549861707 2003 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 46:S49-S57
Macpherson GR; Franks M; Tomoaia-Cotisel A; Ando Y; Price DK; Figg WD
Current status of thalidomide and its role in the treatment of metastatic prostate cancer
12
364874607 1997 INTERNATIONAL JOURNAL OF DERMATOLOGY 36(12):881-887
Calderon P; Anzilotti M; Phelps R
Thalidomide in dermatology. New indications for an old drug
2227
374879761 1999 BIODRUGS 11(6):409-416
Powell RJ
Thalidomide - Current uses
12
3848681208 2001 HAUTARZT 52(8):726-733
Kuhn A; Hefter H; Ruzicka T; Lehmann P
Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus
00
394595965 2000 CURRENT OPINION IN ONCOLOGY 12(6):564-573
Thomas DA; Kantarjian HM
Current role of thalidomide in cancer treatment
1641
40441401183 2001 DRUG SAFETY 24(2):87-117
Clark TE; Edom N; Larson J; Lindsey LJ
Thalomid (R) (Thalidomide) capsules - A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing
1114
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
4144671184 2001 DRUGS 61(6):777-787
Bousvaros A; Mueller B
Thalidomide in gastrointestinal disorders
48
4244671806 2003 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 95(5):576-585
Hegarty A; Hodgson T; Porter S
Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis
12
4343651563 2003 AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 4(6):379-387
Pelle MT; Werth VP
Thalidomide in cutaneous lupus erythematosus
00
4442651890 2004 CLINICAL PHARMACOKINETICS 43(5):311-327
Teo SK; Colburn WA; Tracewell WG; Kook KA; Stirling DI; Jaworsky MS; Scheffler MA; Thomas SD; Laskin OL
Clinical pharmacokinetics of thalidomide
11
4541106267 1990 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 117(4):313-321
REVUZ J
THALIDOMIDE
1621
4641120971 2000 DRUGS 60(2):273-292
Peuckmann V; Fisch M; Bruera E
Potential novel uses of thalidomide - Focus on palliative care
2740
4741781812 2003 PHARMACOTHERAPY 23(4):481-493
Okafor MC
Thalidomide for erythema nodosum leprosum and other applications
00
484051997 2000 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 6(1):19-26
Lenardo TM; Calabrese LH
The role of thalidomide in the treatment of rheumatic disease
44
4940531189 2001 EXPERT OPINION ON BIOLOGICAL THERAPY 1(4):675-682
Marriott JB; Muller G; Stirling D; Dalgleish AG
Immunotherapeutic and antitumour potential of thalidomide analogues
1216
5040591709 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(1):92-99
Meierhofer C; Wiedermann CJ
New insights into the pharmacological and toxicological effects of thalidomide
33
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
5140781901 2004 EXPERT OPINION ON THERAPEUTIC PATENTS 14(2):215-229
Luzzio FA; Figg WD
Thalidomide analogues: derivatives of an orphan drug with diverse biological activity
00
5239671479 2002 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 6(2):160-174
Kumar S; Witzig TE; Rajkumar SV
Thalidomide as an anti-cancer agent
610
5339571965 2004 NATURE REVIEWS CANCER 4(4):314-322
Bartlett JB; Dredge K; Dalgleish AG
Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents
22
543852813 1999 IMMUNOLOGY TODAY 20(12):538-540
Marriott JB; Muller G; Dalgleish AG
Thalidomide as an emerging immunotherapeutic agent
3847
5537441218 2001 JOINT BONE SPINE 68(6):582-587
Combe B
Thalidomide: new indications?
13
5637671494 2002 JOURNAL OF IMMUNOLOGY 168(6):2644-2651
Majumdar S; Lamothe B; Aggarwal BB
Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester
1225
5736601164 2001 CELLULAR AND MOLECULAR BIOLOGY 47(7):1105-1114
Settles B; Stevenson A; Wilson K; Mack C; Ezell T; Davis MF; Taylor LD
Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide
710
5835951817 2003 SCHMERZ 17(3):204-+
Peuckmann V; Strumpf M; Zenz M; Bruera E
Novel potential uses of thalidomide in the management of pain? A review of the literature
00
5933371421 2002 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 130(1):75-84
Marriott JB; Clarke IA; Dredge K; Muller G; Stirling D; Dalgleish AG
Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells
1719
6033531434 2002 CURRENT OPINION IN ONCOLOGY 14(6):635-640
Raje N; Anderson KC
Thalidomide and immunomodulatory drugs as cancer therapy
814
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
6132441068 2001 AMERICAN JOURNAL OF THE MEDICAL SCIENCES 321(5):321-326
Moraes M; Russo G
Thalidomide and its dermatologic uses
39
6232401867 2004 BRITISH JOURNAL OF CANCER 90(5):955-961
Bartlett JB; Michael A; Clarke IA; Dredge K; Nicholson S; Kristeleit H; Polychronis A; Pandha H; Muller GW; Stirling DI; Zeldis J; Dalgleish AG
Phase 1 study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
11
633189351 1993 ARCHIVES OF TOXICOLOGY 67(1):1-17
NEUBERT R; NOGUEIRA AC; NEUBERT D
THALIDOMIDE DERIVATIVES AND THE IMMUNE-SYSTEM .1. CHANGES IN THE PATTERN OF INTEGRIN RECEPTORS AND OTHER SURFACE-MARKERS ON LYMPHOCYTE-T SUBPOPULATIONS OF MARMOSET BLOOD
4049
6431671160 2001 CANCER 92(9):2364-2373
Tseng JE; Glisson BS; Khuri FR; Shin DM; Myers JN; El-Naggar AK; Roach JS; Ginsberg LE; Thall PF; Wang XM; Teddy S; Lawhorn KN; Zentgraf RE; Steinhaus GD; Pluda JM; Abbruzzese JL; Hong WK; Herbst RS
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
714
653053753 1999 ARCHIVES OF DERMATOLOGY 135(9):1079-1087
Duong DJ; Spigel GT; Moxley RT; Gaspari AA
American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus
2029
6630491178 2001 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 126(42):1178-1182
Tuinmann G; Hegewisch-Becker S; Hossfeld DK
New indications for thalidomide
23
6730711305 2002 BIOLOGICAL & PHARMACEUTICAL BULLETIN 25(5):597-604
Marks MG; Shi JD; Fry MO; Xiao ZL; Trzyna M; Pokala V; Ihnat MA; Li PK
Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation
69
6830451312 2002 BIOMEDICINE & PHARMACOTHERAPY 56(4):194-199
Ng SSW; Brown M; Figg WD
Thalidomide, an antiangiogenic agent with clinical activity in cancer
56
6930591390 2002 BLOOD REVIEWS 16(4):207-215
Strasser K; Ludwig H
Thalidomide treatment in multiple myeloma
34
702960697 1998 EXPERIMENTAL HEMATOLOGY 26(3):217-221
Or R; Feferman R; Shoshan S
Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs
1824
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
712979751 1999 ANNALS OF THE RHEUMATIC DISEASES 58:107-113
Corral LG; Kaplan G
Immunomodulation by thalidomide and thalidomide analogues
1318
7229421242 2001 LUPUS 10(3):188-192
Karim MY; Ruiz-Irastorza G; Khamashta MA; Hughes GRV
Update on therapy - thalidomide in the treatment of lupus
613
7329561973 2004 TOXICOLOGICAL SCIENCES 81(2):379-389
Teo SK; Denny KH; Stirling DI; Thomas SD; Morseth S; Hoberman AM
Effects of thalidomide on developmental, peri-and postnatal function in female New Zealand white rabbits and offspring
00
742838354 1993 BONE MARROW TRANSPLANTATION 12:S26-S28
EHNINGER G; EGER K; STUHLER A; SCHULER U
THALIDOMIDE - THE NEED FOR A NEW CLINICAL-EVALUATION OF AN OLD DRUG
78
752850589 1997 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 110(2):151-154
McHugh SM; Rowland TL
Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation
1732
7628701254 2001 ONCOLOGY-NEW YORK 15(7):867-874
Rajkumar SV
Current status of thalidomide in the treatment of cancer
914
7727361014 2000 JOURNAL OF PHARMACY AND PHARMACOLOGY 52(7):807-817
Eriksson T; Bjorkman S; Roth B; Hoglund P
Intravenous formulations of the enantiomers of thalidomide: Pharmacokinetic and initial pharmacodynamic characterization in man
1017
7827531219 2001 JOURNAL OF BIOLOGICAL CHEMISTRY 276(25):22382-22387
Keifer JA; Guttridge DC; Ashburner BP; Baldwin AS
Inhibition of NF-kappa B activity by thalidomide through suppression of I kappa B kinase activity
3357
7927341297 2002 ANNALS OF PHARMACOTHERAPY 36(3):521-525
Bessmertny O; Pham T
Thalidomide use in pediatric patients
12
8027441472 2002 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 83(2):99-104
Arrieta O; Guevara P; Tamariz J; Rembao D; Rivera E; Sotelo J
Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma
13
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
8127371576 2003 ANNALS OF HEMATOLOGY 82(9):558-564
Huang SY; Tang JL; Yao M; Ko BS; Hong RL; Tsai W; Wang CH; Tien HF; Shen MC; Chen YC
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma
00
8227541946 2004 LEUKEMIA 18(4):856-863
Garcia-Sanz R; Gonzalez-Porras JR; Hernandez JM; Polo-Zarzuela M; Sureda A; Barrenetxea C; Palomera L; Lopez R; Grande-Garcia C; Alegre A; Vargas-Pabon M; Gutierrez ON; Rodriguez JA; San Miguel JF
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma
01
8326174893 2000 BIOCHEMICAL PHARMACOLOGY 59(12):1489-1499
Stephens TD; Bunde CJW; Fillmore BJ
Mechanism of action in thalidomide teratogenesis
2436
84261231176 2001 CURRENT OPINION IN ONCOLOGY 13(5):374-381
Krown SE
Management of Kaposi sarcoma: the role of interferon and thalidomide
217
8526911313 2002 BIOORGANIC & MEDICINAL CHEMISTRY 10(3):461-479
Hashimoto Y
Structural development of biological response modifiers based on thalidomide
815
8626381698 2003 CLINICAL CANCER RESEARCH 9(5):1680-1688
Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Muller G; Ching LM
Thalidomide metabolites in mice and patients with multiple myeloma
78
8726381790 2003 LEUKEMIA & LYMPHOMA 44(7):1141-1146
Flowers MED; Martin PJ
Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease
00
882561378 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(2):65-76
DARCY PF; GRIFFIN JP
THALIDOMIDE REVISITED
2227
892552830 1999 JOURNAL OF INVESTIGATIVE DERMATOLOGY 113(5):720-724
Nasca MR; O'Toole EA; Palicharla P; West DP; Woodley DT
Thalidomide increases human keratinocyte migration and proliferation
615
9025541425 2002 CLINICAL CANCER RESEARCH 8(6):1964-1973
Ando Y; Fuse E; Figg WD
Thalidomide metabolism by the CYP2C subfamily
1415
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
9125471847 2004 ARCHIVES OF DERMATOLOGY 140(7):845-849
Maurer T; Poncelet A; Berger T
Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects - Efficacy and risk of neuropathy
00
9225451935 2004 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 50(2):235-241
Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbe C; Morel P; Rybojad M
Treatment of cutaneous sarcoidosis with thalidomide
00
9324321149 2001 BRITISH JOURNAL OF DERMATOLOGY 144(2):310-315
Chave TA; Finlay AY; Knight AG; All-Wales Dermatology Audit Comm
Thalidomide usage in Wales: the need to follow guidelines
11
9424281234 2001 JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 32(3):322-324
Strauss RS; Das FM
Thalidomide-induced sensory neuropathy
23
9524391389 2002 BLOOD 100(12):4162-4168
Yaccoby S; Johnson CL; Mahaffey SC; Wezeman MJ; Barlogie B; Epstein J
Antimyeloma efficacy of thalidomide in the SCID-hu model
16
9624471857 2004 BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY 71(1):1-16
Teo SK; Denny KH; Stirling DI; Thomas SD; Morseth SL; Hoberman AM
Effects of thalidomide on reproductive function and early embryonic development in male and female New Zealand white rabbits
11
9724521895 2004 DRUGS OF TODAY 40(3):197-204
Joglekar S; Levin M
The promise of thalidomide: Evolving indications
00
9824421925 2004 JOURNAL OF IMMUNOLOGY 172(8):5103-5109
Gockel HR; Lugering A; Heidemann J; Schmidt M; Domschke W; Kucharzik T; Lugering N
Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway
00
992342388 1994 BONE MARROW TRANSPLANTATION 14(6):937-942
COLE CH; ROGERS PCJ; PRITCHARD S; PHILLIPS G; CHAN KW
THALIDOMIDE IN THE MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATION
2530
1002338450 1995 CLINICAL INFECTIOUS DISEASES 20(2):250-254
PATERSON DL; GEORGHIOU PR; ALLWORTH AM; KEMP RJ
THALIDOMIDE AS TREATMENT OF REFRACTORY APHTHOUS ULCERATION RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
3860
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1012379845 1999 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 425(1):153-167
Zhu XY; Zhang YP; Klopman G; Rosenkranz HS
Thalidomide and metabolites: indications of the absence of 'genotoxic' carcinogenic potentials
33
1022345952 2000 CANCER CHEMOTHERAPY AND PHARMACOLOGY 46(2):135-141
Kestell P; Zhao LL; Baguley BC; Palmer BD; Muller G; Paxton JW; Ching LM
Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide
621
10323551257 2001 OPHTHALMIC RESEARCH 33(5):256-263
Baatz H; Tonessen B; Prada J; Pleyer U
Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis
14
10423521278 2001 TOXICOLOGICAL SCIENCES 59(1):160-168
Teo SK; Evans MG; Brockman MJ; Ehrhart J; Morgan JM; Stirling DI; Thomas SD
Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs
55
10523421495 2002 JOURNAL OF IMMUNOLOGY 168(10):4914-4919
Dredge K; Marriott JB; Todryk SM; Muller GW; Chen R; Stirling DI; Dalgleish AG
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
1429
10623301500 2002 JOURNAL OF LEUKOCYTE BIOLOGY 72(5):939-945
Mohty M; Stoppa AM; Blaise D; Isnardon D; Gastaut JA; Olive D; Gaugler A
Differential regulation of dendritic cell function by the immunomodulatory drug thalidomide
26
10723391796 2003 MAYO CLINIC PROCEEDINGS 78(1):34-39
Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Geyer SM; Iturria NL; Fonseca R; Hayman SR; Lust JA; Kyle RA; Greipp PR; Witzig TE; Rajkumar SV
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma
921
1082261117 1984 INTERNATIONAL JOURNAL OF DERMATOLOGY 23(9):598-602
GROSSHANS E; ILLY G
THALIDOMIDE THERAPY FOR INFLAMMATORY DERMATOSES
5562
1092233549 1996 LUPUS 5(4):257-258
Stevens RJ
The place of thalidomide in the treatment of inflammatory disease
35
1102280694 1998 CURRENT MEDICINAL CHEMISTRY 5(3):163-178
Hashimoto Y
Novel biological response modifiers derived from thalidomide
1638
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1112230745 1999 AIDS RESEARCH AND HUMAN RETROVIRUSES 15(12):1047-1052
Noormohamed FH; Youle MS; Higgs CJ; Kook KA; Hawkins DA; Lant AF; Thomas SD
Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjects
1313
1122235787 1999 CANCER CHEMOTHERAPY AND PHARMACOLOGY 43:S78-S84
Dixon SC; Kruger EA; Bauer KS; Figg WD
Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
814
1132232809 1999 GASTROENTEROLOGY 117(6):1485-1488
Sands BE; Podolsky DK
New life in a sleeper: Thalidomide and Crohn's disease
825
11422341554 2002 THERAPEUTIC DRUG MONITORING 24(1):104-110
Price DK; Ando Y; Kruger EA; Weiss M; Figg WD
5 '-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis
910
11522301582 2003 ANTI-CANCER DRUGS 14(5):331-335
Dredge K; Dalgleish AG; Marriott JB
Thalidomide analogs as emerging anti-cancer drugs
38
11622281692 2003 CANCER RESEARCH 63(3):593-599
Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins
714
11722331888 2004 CLINICAL CANCER RESEARCH 10(17):5949-5956
Chung F; Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Tingle M; Ching LM
Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients
00
1182164263 1989 MEDICAL HYPOTHESES 30(2):105-109
GUNZLER V
THALIDOMIDE - A THERAPY FOR THE IMMUNOLOGICAL CONSEQUENCES OF HIV INFECTION
46
11921108634 1997 MEDICAL HYPOTHESES 49(2):123-131
McCarty MF
Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: Potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis
1731
1202144644 1997 NEW ENGLAND JOURNAL OF MEDICINE 336(21):1487-1493
Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection
119192
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
12121401005 2000 JOURNAL OF CLINICAL ONCOLOGY 18(14):2710-2717
Baidas SM; Winer EP; Fleming GF; Harris L; Pluda JM; Crawford JG; Yamauchi H; Isaacs C; Hanfelt J; Tefft M; Flockhart D; Johnson MD; Hawkins MJ; Lippman ME; Hayes DF
Phase II evaluation of thalidomide in patients with metastatic breast cancer
3954
12221301073 2001 ANNALS OF ONCOLOGY 12(7):885-886
Thomas DA; Kantarjian HM
The revitalization of thalidomide
45
12321361283 2002 ALIMENTARY PHARMACOLOGY & THERAPEUTICS 16(6):1117-1124
Sabate JM; Villarejo J; Lemann M; Bonnet J; Allez M; Modigliani R
An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease
415
12421371490 2002 JOURNAL OF CLINICAL ONCOLOGY 20(21):4319-4323
Rajkumar SV; Hayman S; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR; Geyer S; Iturria N; Fonseca R; Lust JA; Kyle RA; Witzig TE
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
3357
12521421956 2004 MAYO CLINIC PROCEEDINGS 79(7):883-889
Mesa RA; Elliott MA; Schroeder G; Tefferi A
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia
11
12621451964 2004 MOLECULES AND CELLS 17(2):210-216
Kim YS; Kim JS; Jung HC; Song IS
The effects of thalidomide on the stimulation of NF-kappa B activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line
00
1272085379 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(4):177-192
CRAWFORD CL
USE OF THALIDOMIDE IN LEPROSY
811
1282052456 1995 EXPERIMENTAL HEMATOLOGY 23(9):978-985
FERNANDEZ LP; SCHLEGEL PG; BAKER J; CHEN YF; CHAO NJ
DOES THALIDOMIDE AFFECT IL-2 RESPONSE AND PRODUCTION
2121
1292042786 1999 BRITISH JOURNAL OF CANCER 80(5-6):716-723
Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
1126
1302033807 1999 GASTROENTEROLOGY 117(6):1271-1277
Ehrenpreis ED; Kane SV; Cohen LB; Cohen RD; Hanauer SB
Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial
44132
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1312098954 2000 CANCER TREATMENT REVIEWS 26(5):351-362
Rajkumar SV; Witzig TE
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma
2953
13220321224 2001 JOURNAL OF CLINICAL PHARMACOLOGY 41(6):662-667
Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD
Thalidomide dose proportionality assessment following single doses to healthy subjects
34
13320481263 2001 QUIMICA NOVA 24(5):683-688
Lima LM; Fraga CAM; Barreiro EJ
The rebirth of a drug: Thalidomide
01
13420241487 2002 JOURNAL OF CLINICAL ONCOLOGY 20(11):2607-2609
Eisen T
Thalidomide in solid malignancies
612
13520321555 2002 THERAPIE 57(6):524-529
Boulin M; Blanchet F; Isambert N; Solary E; Solier S; Collin B; Pernot C; Durnet-Archeray MJ
Role of thalidomide with or without dexamethasone for refractory multiple myeloma
00
1361939270 1990 BIOMEDICINE & PHARMACOTHERAPY 44(4):199-204
HENEY D; BAILEY CC; LEWIS IJ
THALIDOMIDE IN THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE
1214
1371942593 1997 CLINICAL NEUROPHARMACOLOGY 20(2):152-164
Zhu J; Bai XF; Mix E; vanderMeide PH; Zwingenberger K; Link H
Thalidomide suppresses T-and B-cell responses to myelin antigen in experimental allergic neuritis
34
1381933703 1998 IMMUNOPHARMACOLOGY 40(1):11-20
Rowland TL; McHugh SM; Deighton J; Dearman RJ; Ewan PW; Kimber I
Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells
3648
1391937708 1998 JOURNAL OF EXPERIMENTAL MEDICINE 187(11):1885-1892
Haslett PAJ; Corral LG; Albert M; Kaplan G
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
144179
1401936802 1999 ETHIOPIAN MEDICAL JOURNAL 37(4):275-280
Shannon EJ
24th Kellersberger Memorial Lecture, 1999 thalidomide: Will the past overshadow a promising future?
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1411938886 2000 ANTI-CANCER DRUGS 11(10):787-791
Adlard JW
Thalidomide in the treatment of cancer
511
1421940987 2000 HUMAN & EXPERIMENTAL TOXICOLOGY 19(11):615-622
Teo S; Evans M; Ehrhart J; Brockman M; Allen D; Morgan M; Stirling D; Thomas S
Lack of peripheral neuropathy in Beagle dogs after 53 weeks oral administration of thalidomide capsules
00
14319471274 2001 SEMINARS IN ONCOLOGY 28(6):597-601
D'Amato RJ; Lentzsch S; Anderson KC; Rogers MS
Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma
010
14419511416 2002 CANCER INVESTIGATION 20(7-8):1051-1058
Jaslow R; Kaplan G; Lyons L; Michaeli J; Coleman M
Thalidomide in multiple myeloma-from the clinic to the laboratory
00
14519361445 2002 EUROPEAN JOURNAL OF PHARMACOLOGY 453(2-3):325-334
Thiele A; Bang R; Gutschow M; Rossol M; Loos S; Eger K; Tiegs G; Hauschildt S
Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide
13
14619301474 2002 INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE 6(7):569-572
Fu LM; Fu-Liu CS
Thalidomide and tuberculosis
23
14719501676 2003 BRITISH JOURNAL OF HAEMATOLOGY 120(1):18-26
Cavenagh JD; Oakervee H; UK Myeloma Forum; BSCH Haematology Oncology Task For
Thalidomide in multiple myeloma: Current status and future prospects
1518
14819401682 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(4):607-616
Kropff MH; Lang N; Bisping G; Domine N; Innig G; Hentrich M; Mitterer M; Sudhoff T; Fenk R; Straka C; Heinecke A; Koch OM; Ostermann H; Berdel WE; Kienast J
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
59
14919311693 2003 CANCER RESEARCH 63(12):3189-3194
Ng SSW; Gutschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD
Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues
46
15019401750 2003 JOURNAL OF INFECTIOUS DISEASES 187(6):946-955
Haslett PAJ; Hanekom WA; Muller G; Kaplan G
Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8(+) T cells in vitro
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
15119461752 2003 JOURNAL OF INVESTIGATIVE DERMATOLOGY 121(5):1060-1065
Deng L; Ding WH; Granstein RD
Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells
11
15219321762 2003 JOURNAL OF RHEUMATOLOGY 30(12):2627-2631
Wei JCC; Chan TW; Lin HS; Huang F; Chou CT
Thalidomide for severe refractory ankylosing spondylitis: A 6-month open-label trial
01
15319361792 2003 LEUKEMIA & LYMPHOMA 44(9):1489-1493
Steins MB; Bieker R; Padro T; Kessler T; Kienast J; Berdel WE; Mesters RM
Thalidomide for the treatment of acute myeloid leukemia
00
15419251807 2003 ORGANIC LETTERS 5(16):2865-2867
Capitosti SM; Hansen TP; Brown ML
Facile synthesis of an azido-labeled thalidomide analogue
02
15519911845 2004 ANTIOXIDANTS & REDOX SIGNALING 6(1):1-14
Hansen JM; Harris C
A novel hypothesis for thalidomide-induced limb teratogenesis: Redox misregulation of the NF-kappa B pathway
00
15619371909 2004 HAEMATOLOGICA 89(7):826-831
Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; De Vivo A; Palareti G; Tura S; Baccarani M
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma
00
1571823620 1997 JOURNAL OF AOAC INTERNATIONAL 80(4):767-773
Reepmeyer JC; Cox DC
Liquid chromatographic determination of thalidomide in tablets, capsules, and raw materials
04
1581827992 2000 INTERNATIONAL JOURNAL OF DERMATOLOGY 39(5):383-388
Walchner M; Meurer M; Plewig G; Messer G
Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus
1627
15918371061 2000 TOXICOLOGY AND APPLIED PHARMACOLOGY 165(3):237-244
Karrow NA; McCay JA; Brown RD; Musgrove DL; Pettit DA; Munson AE; Germolec DR; White KL
Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice
58
16018361212 2001 INFLAMMATION 25(2):91-96
Belo AV; Ferreira MAND; Bosco AA; Machado RDP; Andrade SP
Differential effects of thalidomide on angiogenesis and tumor growth in mice
02
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
16118261222 2001 JOURNAL OF CLINICAL ONCOLOGY 19(16):3593-3595
Rajkumar SV; Kyle RA
Thalidomide in the treatment of plasma cell malignancies
67
16218271301 2002 ARCHIVOS DE BRONCONEUMOLOGIA 38(10):492-494
Valero FC; Gonzalez VB
Lung toxicity due to thalidomide
11
16318361317 2002 BLOOD 99(3):834-839
Steins MB; Padro T; Bieker R; Ruiz S; Kropff M; Kienast J; Kessler T; Buechner T; Berdel WE; Mesters RM
Efficacy and safety of thalidomide in patients with acute myeloid leukemia
1125
16418231459 2002 HAEMATOLOGICA 87(3):233-234
Tosi P; Cavo M
Thalidomide in multiple myeloma: state of art
34
16518281537 2002 ONCOLOGY-NEW YORK 16(1):22-24
Richardson P; Anderson K
Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease - Drs. Paul Richardson and Kenneth Anderson respond
00
16618421604 2003 BLOOD 102(1):69-77
Mileshkin L; Biagi JJ; Mitchell P; Underhill C; Grigg A; Bell R; McKendrick J; Briggs P; Seymour JF; Lillie K; Smith JG; Zeldis JB; Prince HM
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age
710
16718311838 2004 ANNALS OF HEMATOLOGY 83(7):467-470
Witzens M; Moehler T; Neben K; Fruehauf S; Hartschuh W; Ho AD; Goldschmidt H
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide
00
1681741348 1993 ARCHIVES OF DERMATOLOGY 129(10):1261-1264
THOMAS L; DUCROS B; SECCHI T; BALME B; MOULIN G
SUCCESSFUL TREATMENT OF ADULTS LANGERHANS CELL HISTIOCYTOSIS WITH THALIDOMIDE - REPORT OF 2 CASES AND LITERATURE-REVIEW
2340
1691733359 1993 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 11(5):487-493
ATRA E; SATO EI
TREATMENT OF THE CUTANEOUS LESIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE
4765
1701732887 2000 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 44(9):2286-2290
Verbon A; Juffermans NP; Speelman P; van Deventer SJH; ten Berge IJM; Guchelaar HJ; van der Poll T
A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans
1718
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
1711719998 2000 JOINT BONE SPINE 67(4):259-261
Wendling D; Toussirot E; Michel F
Thalidomide: a comeback?
14
17217271015 2000 JOURNAL OF RHEUMATOLOGY 27(6):1429-1433
Ordi-Ros J; Cortes F; Cucurull E; Mauri M; Bujan S; Vilardell M
Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy
1528
17317331202 2001 HAEMATOLOGICA 86(4):409-413
Tosi P; Ronconi S; Zamagni E; Cellini C; Grafone T; Cangini D; Pileri SA; Baccarani M; Tura S; Cavo M
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation
1321
17417421308 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):13-19
Sampaio EP; Hernandez MO; Carvalho DS; Sarno EN
Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M-leprae-induced TNF alpha production in vitro
56
17517481310 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):31-35
Shek LPC; Lim DLC
Thalidomide in Behcet's disease
711
17617241428 2002 CLINICAL CANCER RESEARCH 8(11):3377-3382
Neben K; Moehler T; Benner A; Kraemer A; Egerer G; Ho AD; Goldschmidt H
Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma
913
17717241499 2002 JOURNAL OF INVESTIGATIVE DERMATOLOGY 119(5):1020-1026
Bastuji-Garin S; Ochonisky S; Bouche P; Gherardi RK; Duguet C; Djerradine Z; Poli F; Revuz J; Thalidomide Neuropathy Study Grp
Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients
912
17817381526 2002 LUPUS 11(2):67-70
Piette JC; Sbai A; Frances C
Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus
35
17917351553 2002 TERATOLOGY 66(3):115-121
Stromland K; Philipson E; Gronlund MA
Offspring of male and female parents with thalidomide embryopathy: Birth defects and functional anomalies
35
18017471850 2004 BIOCHEMICAL PHARMACOLOGY 68(7):1321-1329
Fernandez-Martinez E; Morales-Rios MS; Perez-Alvarez V; Muriel P
Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
18117251915 2004 INTERNATIONAL JOURNAL OF HEMATOLOGY 79(3):283-288
Hattori Y; Kakimoto T; Okamoto S; Sato N; Ikeda Y
Thalidomide-induced severe neutropenia during treatment of multiple myeloma
00
18217321924 2004 JOURNAL OF CLINICAL ONCOLOGY 22(16):3269-3276
Schey SA; Fields P; Bartlett JB; Clarke IA; Ashan G; Knight RD; Streetly M; Dalgleish AG
Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma
11
1831645426 1994 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 40(5):535-542
ARALACHAVES M; VILANOVA M; RIBEIRO A; PINTO J
IMMUNOSTIMULATORY EFFECT OF THALIDOMIDE IN NORMAL C57BL/6 MICE IS COMPATIBLE WITH STIMULATION OF A HIGHLY CONNECTED CENTRAL IMMUNE-SYSTEM .1.
46
1841623583 1997 BRITISH JOURNAL OF RHEUMATOLOGY 36(3):353-359
Stevens RJ; Andujar C; Edwards CJ; Ames PRJ; Barwick AR; Khamashta MA; Hughes GRV
Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: Experience in sixteen consecutive patients
3649
1851627715 1998 JOURNAL OF PHARMACY AND PHARMACOLOGY 50(12):1409-1416
Eriksson T; Bjorkman S; Roth B; Bjork H; Hoglund P
Hydroxylated metabolites of Thalidomide: Formation in-vitro and in-vivo in man
2425
1861640808 1999 GASTROENTEROLOGY 117(6):1278-1287
Vasiliauskas EA; Kam LY; Abreu-Martin MT; Hassard PV; Papadakis KA; Yang HY; Zeldis JB; Targan SR
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease
43129
1871628834 1999 JOURNAL OF PHARMACEUTICAL SCIENCES 88(1):121-125
Figg WD; Raje S; Bauer KS; Tompkins A; Venzon D; Bergan R; Chen A; Hamilton M; Pluda J; Reed E
Pharmacokinetics of thalidomide in an elderly prostate cancer population
3448
1881639855 1999 ORGANIC LETTERS 1(10):1571-1573
Takeuchi Y; Shiragami T; Kimura K; Suzuki E; Shibata N
(R)- and (S)-3-fluorothalidomides: Isosteric analogues of thalidomide
314
1891622991 2000 INTERNATIONAL JOURNAL OF DERMATOLOGY 39(3):218-222
Kyriakis KP; Kontochristopoulos GJ; Panteleos DN
Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus
1017
19016591047 2000 QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS 93(5):305-311
Davey PP; Ashrafian H
New therapies for heart failure: is thalidomide the answer?
69
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
19116371147 2001 BRITISH JOURNAL OF CANCER 85(7):953-958
Stebbing J; Benson C; Eisen T; Pyle L; Smalley K; Bridle H; Mak I; Sapunar F; Ahern R; Gore ME
The treatment of advanced renal cell cancer with high-dose oral thalidomide
1931
19216471185 2001 DRUGS OF THE FUTURE 26(1):100-103
[Anon]
Thalidomide - Synovir (R) - Thalomid (R) - Talizer (R) - Oncolytic treatment of IBD antiarthritic treatment of leprosy
00
19316291413 2002 CANCER BIOLOGY & THERAPY 1(6):669-673
Ando L; Price DK; Dahut WL; Cox MC; Reed E; Figg WD
Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide
00
19416341478 2002 JOURNAL OF CARDIAC FAILURE 8(5):306-314
Agoston I; Dibbs ZI; Wang F; Muller G; Zeldis JB; Mann DL; Bozkurt B
Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure
23
19516241480 2002 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 767(1):145-151
Teo SK; Chandula RS; Harden JL; Stirling DI; Thomas SD
Sensitive and rapid method for the determination of thalidomide in human plasma and semen using solid-phase extraction and liquid chromatography-tandem mass spectrometry
45
19616251702 2003 CLINICAL LYMPHOMA 3(4):241-246
Seldin DC; Choufani EB; Dember LM; Wiesman JF; Berk JL; Falk RH; O'Hara C; Fennessey S; Finn KT; Wright DG; Skinner M; Sanchorawala V
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis
59
19716371713 2003 DRUG METABOLISM AND DISPOSITION 31(4):469-475
Miyata M; Tamura E; Motoki K; Nagata K; Yamazoe Y
Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation
22
19816421730 2003 INTERNATIONAL IMMUNOPHARMACOLOGY 3(10-11):1447-1456
Karrow NA; Guo TL; Zhang LX; McCay JA; Musgrove DL; Peachee VL; Germolec DR; White KL
Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance study
01
19916331837 2004 AMERICAN JOURNAL OF VETERINARY RESEARCH 65(5):659-664
Farese JR; Fox LE; Detrisac CJ; Van Gilder JA; Roberts SL; Baldwin JA
Effect of thalidomide on growth and metastasis of canine osteosarcoma cells after xenotransplantation in athymic mice
00
20016281896 2004 EUROPEAN JOURNAL OF HAEMATOLOGY 72(1):52-57
Strupp C; Germing U; Scherer A; Kundgen A; Modder U; Gattermann N; Haas R
Thalidomide for the treatment of idiopathic myelofibrosis
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2011526268 1990 ARCHIVES OF DERMATOLOGY 126(7):923-927
REVUZ J; GUILLAUME JC; JANIER M; HANS P; MARCHAND C; SOUTEYRAND P; BONNETBLANC JM; CLAUDY A; DALLAC S; KLENE C; CRICKX B; SANCHOGARNIER H; CHAUMEIL JC
CROSSOVER STUDY OF THALIDOMIDE VS PLACEBO IN SEVERE RECURRENT APHTHOUS STOMATITIS
53100
2021543422 1994 POSTGRADUATE MEDICAL JOURNAL 70(830):860-862
GARDNERMEDWIN JM; POWELL RJ
THALIDOMIDE - THE WAY FORWARD
710
2031527608 1997 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 19(5):289-296
Pham-Huy C; Galons H; Voisin J; Zhu JR; Righenzi S; Warnet JM; Claude JR; Duc HT
In vitro and in vivo immunosuppressive potential of thalidomide and its derivative, N-hydroxythalidomide, alone and in combination with cyclosporin A
11
2041533741 1998 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 48(4):397-402
Zhu J; Deng GM; Diab A; Zwingenberger K; Bakhiet M; Link H
Thalidomide prolongs experimental autoimmune neuritis in Lewis rats
410
2051532812 1999 IMMUNOLOGY LETTERS 68(2-3):325-332
Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I
Selective down-regulation of T cell-and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone
1013
2061532972 2000 ELECTROPHORESIS 21(15):3270-3279
Meyring M; Muhlenbrock C; Blaschke G
Investigation of the stereoselective in vitro biotransformation of thalidomide using a dual cyclodextrin system in capillary electrophoresis
717
2071525999 2000 JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY 14(3):140-147
Teo SK; Sabourin PJ; O'Brien K; Kook KA; Thomas SD
Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients
2222
20815191018 2000 LEPROSY REVIEW 71:S117-S120
Kaplan G
Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions
12
20915171275 2001 SEMINARS IN ONCOLOGY 28(6):602-606
Stirling D
Thalidomide: A novel template for anticancer drugs
813
21015821309 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):20-30
Zorat F; Pozzato G
Thalidomide in myelodysplastic syndromes
33
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
21115351463 2002 HAEMATOLOGICA 87(4):408-414
Tosi P; Zamagni E; Cellini C; Ronconi S; Patriarca F; Ballerini F; Musto P; Di Raimondo F; Ledda A; Lauria F; Masini L; Gobbi M; Vacca A; Ria R; Cangini D; Tura S; Baccarani M; Cavo M
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
1929
21215471602 2003 BLOOD 101(7):2534-2541
Mesa RA; Steensma DP; Pardanani A; Li CY; Elliott M; Kaufmann SH; Wiseman G; Gray LA; Schroeder GE; Reeder T; Zeldis JB; Tefferi A
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia
610
21315451755 2003 JOURNAL OF MEDICINAL CHEMISTRY 46(24):5222-5229
Zhu XX; Giordano T; Yu QS; Holloway HW; Perry TA; Lahiri DK; Brossi A; Greig NH
Thiothalidomides: Novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity
22
21415211811 2003 PHARMACOTHERAPY 23(3):315-318
Horne MK; Figg WD; Arlen P; Gulley J; Parker C; Lakhani N; Parnes H; Dahut WL
Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer
34
21515161834 2004 AMERICAN JOURNAL OF CARDIOLOGY 93(8):1052-1055
Fahdi IE; Gaddam V; Saucedo JF; Kishan CV; Vyas K; Deneke MG; Razek H; Thorn B; Bissett JK; Anaisse E; Barlogie B; Mehta JL
Bradycardia during therapy for multiple myeloma with thalidomide
00
21615151875 2004 CANADIAN JOURNAL OF GASTROENTEROLOGY 18(2):101-104
Hershfield NB
Disappearance of Chron's ulcers in the terminal ileum after thalidomide therapy
00
21715301897 2004 EUROPEAN JOURNAL OF HAEMATOLOGY 72(6):403-409
Offidani M; Corvatta L; Marconi M; Malerba L; Mele A; Olivieri A; Brunori M; Catarini M; Candela M; Capelli D; Montanari M; Rupoli S; Leoni P
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy
00
21815591951 2004 LEUKEMIA RESEARCH 28(4):325-332
Musto P
Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives
00
21915441954 2004 MAYO CLINIC PROCEEDINGS 79(7):857-858
Silver RT
Myelofibrosis: Thalidomide finds a new disease
00
22015161966 2004 NEUROLOGY 62(12):2158-2159
Apfel SC; Zochodne DW
Thalidomide neuropathy - Too much or too long?
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2211422402 1994 DERMATOLOGY 189(2):179-181
BIELSA I; TEIXIDO J; RIBERA M; FERRANDIZ C
ERYTHRODERMA DUE TO THALIDOMIDE - REPORT OF 2 CASES
1317
2221425445 1995 CHIRALITY 7(1):44-52
ERIKSSON T; BJORKMAN S; ROTH B; FYGE A; HOGLUND P
STEREOSPECIFIC DETERMINATION, CHIRAL INVERSION IN-VITRO AND PHARMACOKINETICS IN HUMANS OF THE ENANTIOMERS OF THALIDOMIDE
5780
2231444469 1995 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 32(5):866-869
CARLESIMO M; GIUSTINI S; ROSSI A; BONACCORSI P; CALVIERI S
TREATMENT OF CUTANEOUS AND PULMONARY SARCOIDOSIS WITH THALIDOMIDE
4884
2241438474 1995 LIFE SCIENCES 58(4):295-316
Neubert R; Hinz N; Thiel R; Neubert D
Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide
37
2251424524 1996 EUROPEAN JOURNAL OF DERMATOLOGY 6(5):373-376
Charue D; Chauvin E; Duguet C; Revuz J; Bagot M
Thalidomide decreases the production of GM-CSF and TNF-alpha in the mixed epidermal cell-lymphocyte reaction
12
2261426543 1996 JOURNAL OF MEDICINAL CHEMISTRY 39(17):3238-3240
Muller GW; Corral LG; Shire MG; Wang H; Moreira A; Kaplan G; Stirling DI
Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity
3449
2271423681 1998 BONE MARROW TRANSPLANTATION 21(6):577-581
Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasiulli A; Vassallo E; Miniero R; Uderzo C
The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
2737
2281430709 1998 JOURNAL OF IMMUNOLOGY 161(8):4236-4243
Marriott JB; Westby M; Cookson S; Guckian M; Goodbourn S; Muller G; Shire MG; Stirling D; Dalgleish AG
CC-3052: A water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production
3450
22914321090 2001 BIOORGANIC & MEDICINAL CHEMISTRY 9(4):1059-1065
Gutschow M; Hecker T; Thiele A; Hauschildt S; Eger K
Aza analogues of thalidomide: Synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro
38
23014631181 2001 DRUG DEVELOPMENT RESEARCH 54(4):209-218
Fernandez-Martinez E; Morales-Rios MS; Perez-Alvarez V; Muriel P
Effects of thalidomide and 3-phthalimido-3-(3,4-dimethoxyphenyl)-propanamide on bile duct obstruction-induced cirrhosis in the rat
23
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
23114291420 2002 CHEST 122(1):227-232
Baughman RP; Judson MA; Teirstein AS; Moller DR; Lower EE
Thalidomide for chronic sarcoidosis
427
23214181424 2002 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 20(6):S158-S161
Huang F; Wei JCC; Breban M
Thalidomide in ankylosing spondylitis
01
23314221462 2002 HAEMATOLOGICA 87(4):345-346
[Anon]
Inside Haematologica: caution in the use of thalidomide for treatment of hematologic disorders
00
23414281476 2002 JAPANESE JOURNAL OF CANCER RESEARCH 93(9):1029-1036
Kakimoto T; Hattori Y; Okamoto S; Sato N; Kamata T; Yamaguchi M; Morita K; Yamada T; Takayama N; Uchida H; Shimada N; Tanigawara Y; Ikeda Y
Thalidomide for the treatment of refractory multiple myeloma: Association of plasma concentrations of thalidomide and angiogenic growth factors with clinical outcome
33
23514241585 2003 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 47(8):2445-2449
Giamarellos-Bourboulis EJ; Poulaki H; Kostomitsopoulos N; Dontas I; Perrea D; Karayannacos PE; Giamarellou H
Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide
01
23614321736 2003 INVESTIGATIONAL NEW DRUGS 21(3):359-366
Dal Lago L; Richter MF; Cancela AI; Fernandes SA; Jung KT; Rodrigues AC; Dalla Costa T; Di Leone LP; Schwartsmann G
Phase II trial and pharmacokinetic study of thalidomide in patients with metastatic colorectal cancer
11
23714231820 2003 SEMINARS IN HEMATOLOGY 40(4):8-16
Dimopoulos MA; Anagnostopoulos A
Thalidomide in relapsed/refractory multiple myeloma: Pivotal trials conducted outside the United States
00
23814231917 2004 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 60(2):353-357
Chang SM; Lamborn KR; Malec M; Larson D; Wara W; Sneed P; Rabbitt J; Page M; Nicholas MK; Prados MD
Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
00
23914231930 2004 JOURNAL OF MEDICINAL CHEMISTRY 47(9):2219-2227
Lepper ER; Ng SSW; Gutschow M; Weiss M; Hauschildt S; Hecker TK; Luzzio FA; Eger K; Figg WD
Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors
00
24014271934 2004 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 310(2):571-577
Lu J; Helsby N; Palmer BD; Tingle M; Baguley BC; Kestell P; Ching LM
Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans
00
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
24114201949 2004 LEUKEMIA & LYMPHOMA 45(4):735-738
Balleari E; Ghio R; Falcone A; Musto P
Possible multiple myeloma dedifferentiation following thalidomide therapy: A report of four cases
00
24214271969 2004 ONCOLOGY REPORTS 11(1):93-95
Morabito A; Fanelli M; Carillio G; Gattuso D; Sarmiento R; Gasparini G
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma
00
24314241970 2004 ONKOLOGIE 27(2):150-154
Steurer M; Spizzo G; Mitterer M; Gastl G
Low-dose thalidomide for multiple myeloma: Interim analysis of a compassionate use program
00
24414321975 2004 UROLOGY 63(6):1061-1065
Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma
00
2451339262 1989 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 20(6):1060-1063
GRINSPAN D; BLANCO GF; AGUERO S
TREATMENT OF APHTHAE WITH THALIDOMIDE
924
2461334447 1995 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 99(2):160-167
MCHUGH SM; RIFKIN IR; DEIGHTON J; WILSON AB; LACHMANN PJ; LOCKWOOD CM; EWAN PW
THE IMMUNOSUPPRESSIVE DRUG THALIDOMIDE INDUCES T-HELPER CELL-TYPE 2 (TH2) AND CONCOMITANTLY INHIBITS TH1 CYTOKINE PRODUCTION IN MITOGEN-STIMULATED AND ANTIGEN-STIMULATED HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURES
108145
2471322517 1996 CHIRALITY 8(5):390-396
Wnendt S; Finkam M; Winter W; Ossig J; Raabe G; Zwingenberger K
Enantioselective inhibition of TNF-alpha release by thalidomide and thalidomide-analogues
2834
2481327701 1998 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 236(6):461-466
Kruse FE; Joussen AM; Rohrschneider K; Becker MD; Volcker HE
Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor
3957
2491366727 1998 MEDICAL HYPOTHESES 50(4):313-318
Argiles JM; Carbo N; Lopez-Soriano FJ
Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s?
1112
2501316789 1999 CLEVELAND CLINIC JOURNAL OF MEDICINE 66(3):136-+
Calabrese LH
Thalidomide's tightly controlled "comeback"
33
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2511335864 1999 SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY 12(6):305-311
Monastirli A; Georgiou S; Bolsen K; Pasmatzi E; Papapanagiotou A; Goerz G; Kalofoutis A; Merk HF; Tsambaos D
Treatment of porphyria cutanea tarda with oral thalidomide
57
2521340867 1999 SURGERY 125(5):536-544
Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N
Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice
1227
2531332873 2000 AIDS RESEARCH AND HUMAN RETROVIRUSES 16(14):1345-1355
Kaplan G; Thomas S; Fierer DS; Mulligan K; Haslett PAJ; Fessel WJ; Smith LG; Kook KA; Stirling D; Schambelan M
Thalidomide for the treatment of AIDS-associated wasting
1328
2541333895 2000 BIOPHARMACEUTICS & DRUG DISPOSITION 21(1):33-40
Teo SK; Scheffler MR; Kook KA; Tracewell WG; Colburn WA; Stirling DI; Thomas SD
Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women
66
2551349958 2000 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 121(3):472-479
Guckian M; Dransfield I; Hay P; Dalgleish AG
Thalidomide analogue CC-3052 reduces HIV+ neutrophil apoptosis in vitro
46
2561349960 2000 CLINICAL IMMUNOLOGY 97(2):109-120
Oliver SJ; Moreira A; Kaplan G
Immune stimulation in scleroderma patients treated with thalidomide
1115
25713411002 2000 JOURNAL OF CHROMATOGRAPHY A 876(1-2):157-167
Meyring M; Chankvetadze B; Blaschke G
Simultaneous separation and enantioseparation of thalidomide and its hydroxylated metabolites using high-performance liquid chromatography in common-size columns, capillary liquid chromatography and nonaqueous capillary electrochromatography
332
25813671004 2000 JOURNAL OF CLINICAL ONCOLOGY 18(13):2593-2602
Little RF; Wyvill KM; Pluda JM; Welles L; Marshall V; Figg WD; Newcomb FM; Tosato G; Feigal E; Steinberg SM; Whitby D; Goedert JJ; Yarchoan R
Activity of thalidomide in AIDS-related Kaposis's sarcoma
4583
25913221056 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(5):301-311
Teo S; Morgan M; Stirling D; Thomas S
Assessment of the in vitro and in vivo genotoxicity of Thalomid (R) (Thalidomide)
11
26013411091 2001 BIOORGANIC & MEDICINAL CHEMISTRY 9(5):1279-1291
Hess S; Akermann MA; Wnendt S; Zwingerberger K; Eger K
Synthesis and immunological activity of water-soluble thalidomide prodrugs
24
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
26113231213 2001 INTERNATIONAL IMMUNOPHARMACOLOGY 1(1):49-61
Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I
Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B
58
26213291244 2001 MUSCLE & NERVE 24(8):1050-1057
Molloy FM; Floeter MK; Syed NA; Sandbrink F; Culcea E; Steinberg SM; Dahut W; Pluda J; Kruger EA; Reed E; Figg WD
Thalidomide neuropathy in patients treated for metastatic prostate cancer
1217
26313181265 2001 REVUE DE MEDECINE INTERNE 22(1):5-7
Grosbois B; Duguet C
Thalidomide: the revival
24
26413271286 2002 AMERICAN HEART JOURNAL 144(5):847-850
Gullestad L; Semb AG; Holt E; Skardal R; Ueland T; Yndestad A; Froland SS; Aukrust P
Effect of thalidomide in patients with chronic heart failure
14
26513401291 2002 ANALYTICAL CHEMISTRY 74(15):3726-3735
Meyring M; Muhlbacher J; Messer K; Kastner-Pustet N; Bringmann G; Mannschreck A; Blaschke G
In vitro biotransformation of (R)- and (S)-thalidomide: Application of circular dichroism spectroscopy to the stereochemical characterization of the hydroxylated metabolites
03
26613331411 2002 CANCER 95(4):758-765
Daliani DD; Papandreou CN; Thall PF; Wang XM; Perez C; Oliva R; Pagliaro L; Amato R
A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma
611
26713141443 2002 EUROPEAN JOURNAL OF DERMATOLOGY 12(1):63-65
Frances C; El Khoury S; Gompel A; Becherel PA; Chosidow O; Piette JC
Transient secondary amenorrhea in women treated by thalidomide
12
26813361458 2002 GUT 50(2):196-200
Bauditz J; Wedel S; Lochs H
Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease
1125
26913201461 2002 HAEMATOLOGICA 87(4):344-345
Ribatti D; Vacca A
Is thalidomide a true anti-angiogenic molecule in multiple myeloma?
11
27013151467 2002 HAUTARZT 53(11):744-748
Bohmeyer J; Achenbach A; Westenberger M; Stadler R
Thalidomide therapy of cutaneous lupus erythematosus
11
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
27113251492 2002 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17(2):135-139
Bariol C; Meagher AP; Vickers CR; Byrnes DJ; Edwards PD; Hing M; Wettstein AR; Field A
Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease
813
27213151496 2002 JOURNAL OF INFECTIOUS DISEASES 185(9):1359-1363
Wohl DA; Aweeka FT; Schmitz J; Pomerantz R; Cherng DW; Spritzler J; Fox L; Simpson D; Bell D; Holohan MK; Thomas S; Robinson W; Kaplan G; Teppler H; Natl Inst Allergy Infect Dis AIDS
Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267
55
27313291534 2002 NEUROLOGY 59(12):1872-1875
Chaudhry V; Cornblath DR; Corse A; Freimer M; Simmons-O'Brien E; Vogelsang G
Thalidomide-induced neuropathy
79
27413251589 2003 ARCHIVES OF DERMATOLOGY 139(2):136-138
Thomas P; Walchner M; Ghoreschi K; Rocken M
Successful treatment of granulomatous cheilitis with thalidomide
00
27513351666 2003 BONE MARROW TRANSPLANTATION 32(2):165-170
Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease
12
27613381708 2003 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 46:S59-S65
Amato RJ
Thalidomide therapy for renal cell carcinoma
01
27713231735 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 23(6):1651-1655
Kaicker S; McCrudden KW; Beck L; New T; Huang JZ; Frischer JS; Serur A; Kadenhe-Chiweshe A; Yokoi A; Kandel JJ; Yamashiro DJ
Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma
00
27813361746 2003 JOURNAL OF CLINICAL ONCOLOGY 21(20):3770-3776
Hernberg M; Virkkunen P; Bono P; Atinen H; Maenpaa H; Joensuu H
Interferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinoma
24
27913231761 2003 JOURNAL OF PHARMACY AND PHARMACOLOGY 55(12):1701-1706
Eriksson T; Hoglund P; Turesson I; Waage A; Don BR; Vu J; Scheffler M; Kaysen GA
Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis
33
28013571787 2003 LEUKEMIA & LYMPHOMA 44(2):291-298
Ribas C; Colleoni GWB
Advances in the treatment of multiple myeloma: The role of thalidomide
01
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
28113441805 2003 ONCOLOGY 65(3):242-249
Hsu C; Chen CN; Chen LT; Wu CY; Yang PM; Lai MY; Lee PH; Cheng AL
Low-dose thalidomide treatment for advanced hepatocellular carcinoma
25
28213281879 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 53(5):377-383
Chung F; Wang LCS; Kestell P; Baguley BC; Ching LM
Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor
22
28313261919 2004 JOURNAL OF CHILD NEUROLOGY 19(4):250-257
Schoeman JF; Springer P; van Rensburg AJ; Swanevelder S; Hanekom WA; Haslett PAJ; Kaplan G
Adjunctive thalidomide therapy for childhood tuberculous meningitis: Results of a randomized study
00
28413231937 2004 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 51(1):126-131
Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients
00
28513191972 2004 THROMBOSIS AND HAEMOSTASIS 91(4):834-836
Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making
00
2861223382 1994 ARCHIVES OF DERMATOLOGY 130(1):66-69
OCHONISKY S; VERROUST J; BASTUJIGARIN S; GHERARDI R; REVUZ J
THALIDOMIDE NEUROPATHY INCIDENCE AND CLINICOELECTROPHYSIOLOGIC FINDINGS IN 42 PATIENTS
7397
2871243567 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(10):857-863
Moreira AL; Corral LG; Ye WG; Johnson B; Stirling D; Muller GW; Freedman VH; Kaplan G
Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro
3647
2881221576 1997 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 41(12):2797-2799
Piscitelli SC; Figg WD; Hahn B; Kelly G; Thomas S; Walker RE
Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients
2225
2891227578 1997 BIOCHEMICAL PHARMACOLOGY 53(10):1553-1557
Nicolai S; Sies H; Stahl W
Stimulation of gap junctional intercellular communication by thalidomide and thalidomide analogs in human skin fibroblasts
611
2901221586 1997 CHEMTECH 27(1):21-25
Muller GW
Thalidomide: From tragedy to new drug discovery
49
#LCRNCRNodes / Date / Journal / AuthorsLCSGCS
2911233714 1998 JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS 26(4):363-383
Hoglund P; Eriksson T; Bjorkman S
A double-blind study of the sedative effects of the thalidomide enantiomers in humans
1115
2921239746 1999 AIDS RESEARCH AND HUMAN RETROVIRUSES 15(13):1169-1179
Haslett PAJ; Klausner JD; Makonkawkeyoon S; Moreira A; Metatratip P; Boyle B; Kunachiwa W; Maneekarn N; Vongchan P; Corral LG; Elbeik T; Shen Z; Kaplan G
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients
2733
2931270800 1999 DRUGS 58(6):953-963
Ravot E; Lisziewicz J; Lori F
New uses for old drugs in HIV infection - The role of hydroxyurea, cyclosporin and thalidomide
315
2941234801 1999 ELECTROPHORESIS 20(12):2425-2431
Meyring M; Chankvetadze B; Blaschke G
Enantioseparation of thalidomide and its hydroxylated metabolites using capillary electrophoresis with various cyclodextrins and their combinations as chiral buffer additives
213
2951227821 1999 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 5(5):261-267
Scoville CD; Reading JC
Open trial of thalidomide in the treatment of rheumatoid arthritis
11
2961223833 1999 JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 28(2):214-216
Weinstein TA; Sciubba JJ; Levine J
Thalidomide for the treatment of oral aphthous ulcers in Crohn's disease
1021
2971217863 1999 REVUE DE MEDECINE INTERNE 20(7):567-570
de Wazieres B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL
Treatment of recurrent oro-genital ulceration with low dose of thalidomide. Pilot study in 17 patients
39
2981233961 2000 CLINICAL INFECTIOUS DISEASES 30(5):826-831
Aboulafia DM
Inflammatory pseudotumor causing small bowel obstruction and mimicking lymphoma in a patient with AIDS: Clinical improvement after initiation of thalidomide treatment
14
2991220988 2000 IMMUNOPHARMACOLOGY 46(2):175-179
Shannon E; Aseffa A; Pankey G; Sandoval F; Lutz B
Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+cells in their blood
88
30012441007 2000 JOURNAL OF INFECTIOUS DISEASES 181(3):954-965
Bekker LG; Haslett P; Maartens G; Steyn L; Kaplan G
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis
1827

Page 1:  1  2  3  4  5  6  7
Generated by: HistCite 2004.10.27